Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma: A toxicity study

Edward Neuwelt, K. Clark, J. B. Kirkpatrick, H. Toben

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The feasibility and toxicity of intrathecal lymphoid cell infusions in patients with glioma were examined in this study. Blood rich in lymphoid cells was obtained using the Haemonetics Model 30 cell separator; the lymphoid cells extracted were further purified on Ficoll-Hypaque gradients. Four patients received a total of eighteen autologous lymphoid cell infusions, with between 1 x 106 and 5 x 109 lymphoid cells being infused on each occasion. No toxicity was observed, but the CSF glucose declined in 2 patients. In 1 patient examined at autopsy the lymphoid cells appeared to have gained access to the tumor bed as well as to the rest of the subarachnoid space.

Original languageEnglish (US)
Pages (from-to)307-312
Number of pages6
JournalAnnals of Neurology
Volume4
Issue number4
StatePublished - 1978
Externally publishedYes

Fingerprint

Glioma
Lymphocytes
Diatrizoate
Ficoll
Subarachnoid Space
Clinical Studies
Autopsy
Glucose
Neoplasms

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma : A toxicity study. / Neuwelt, Edward; Clark, K.; Kirkpatrick, J. B.; Toben, H.

In: Annals of Neurology, Vol. 4, No. 4, 1978, p. 307-312.

Research output: Contribution to journalArticle

@article{ddc2f89d97434133adcf69f7fb7f1397,
title = "Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma: A toxicity study",
abstract = "The feasibility and toxicity of intrathecal lymphoid cell infusions in patients with glioma were examined in this study. Blood rich in lymphoid cells was obtained using the Haemonetics Model 30 cell separator; the lymphoid cells extracted were further purified on Ficoll-Hypaque gradients. Four patients received a total of eighteen autologous lymphoid cell infusions, with between 1 x 106 and 5 x 109 lymphoid cells being infused on each occasion. No toxicity was observed, but the CSF glucose declined in 2 patients. In 1 patient examined at autopsy the lymphoid cells appeared to have gained access to the tumor bed as well as to the rest of the subarachnoid space.",
author = "Edward Neuwelt and K. Clark and Kirkpatrick, {J. B.} and H. Toben",
year = "1978",
language = "English (US)",
volume = "4",
pages = "307--312",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma

T2 - A toxicity study

AU - Neuwelt, Edward

AU - Clark, K.

AU - Kirkpatrick, J. B.

AU - Toben, H.

PY - 1978

Y1 - 1978

N2 - The feasibility and toxicity of intrathecal lymphoid cell infusions in patients with glioma were examined in this study. Blood rich in lymphoid cells was obtained using the Haemonetics Model 30 cell separator; the lymphoid cells extracted were further purified on Ficoll-Hypaque gradients. Four patients received a total of eighteen autologous lymphoid cell infusions, with between 1 x 106 and 5 x 109 lymphoid cells being infused on each occasion. No toxicity was observed, but the CSF glucose declined in 2 patients. In 1 patient examined at autopsy the lymphoid cells appeared to have gained access to the tumor bed as well as to the rest of the subarachnoid space.

AB - The feasibility and toxicity of intrathecal lymphoid cell infusions in patients with glioma were examined in this study. Blood rich in lymphoid cells was obtained using the Haemonetics Model 30 cell separator; the lymphoid cells extracted were further purified on Ficoll-Hypaque gradients. Four patients received a total of eighteen autologous lymphoid cell infusions, with between 1 x 106 and 5 x 109 lymphoid cells being infused on each occasion. No toxicity was observed, but the CSF glucose declined in 2 patients. In 1 patient examined at autopsy the lymphoid cells appeared to have gained access to the tumor bed as well as to the rest of the subarachnoid space.

UR - http://www.scopus.com/inward/record.url?scp=0018180952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018180952&partnerID=8YFLogxK

M3 - Article

C2 - 581544

AN - SCOPUS:0018180952

VL - 4

SP - 307

EP - 312

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 4

ER -